SecBot SecBot
PTAB-TRIAL ·Filed Nov 3, 2026

TDOC

Teladoc Health, Inc.
NEUTRAL
Impact 3/10
Horizonmonths Processed1d ago PTABPTAB Decision · ptacts.uspto.gov
PTAB institution decision (instituted)
Actionable Insight • Neutral

Monitor the final written decision expected within ~12 months. If the patent is tied to a material product or service, a cancellation could reduce royalty or litigation exposure.

DirectionNeutral
Confidencemedium
Horizonmonths

Price Chart

Loading chart...

Executive Summary

The PTAB granted institution of IPR2026-00391, finding Teladoc Health showed a reasonable likelihood of prevailing on at least one challenged claim of Data Health Partners' patent (U.S. 11809431, 'System and method for achieving goals'). This is an interlocutory ruling; no claims have been cancelled, and a final written decision is due within about a year.

PTAB Trial Details

Proceeding
IPR2026-00391
Proceeding Type
IPR (inter partes review)
Decision
Trial instituted
Company Role
Petitioner
Outcome for Patent Owner
Pending (trial to come)
Patent
U.S. 11,809,431
Patent Covers
System and method for achieving goals
Challenged Claims
not stated
Next Step
Final written decision due within approximately 12 months

Key Facts

  • PTAB instituted IPR2026-00391 on November 3, 2026
  • Teladoc Health is the petitioner; Data Health Partners is the patent owner
  • Patent U.S. 11809431 covers a system and method for achieving goals
  • Institution granted on merits; no discretionary denial
  • Interlocutory ruling, no claims cancelled yet

Financial Impact

Not stated in the decision; patent's relation to Teladoc's products or revenue is not specified

Risk Factors

  • Patent owner may settle or license before final decision
  • Final decision could uphold some or all claims, limiting benefit to Teladoc
  • Appeal to Federal Circuit possible after final decision

Market Snapshot

Exchange
NYSE
Sector
Services-Offices & Clinics of Doctors of Medicine
Analyst Consensus
34% bullish (29 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 1 PTAB decision.

DocumentAccession Number
PTAB-TRIAL Data (Synthetic)ptab-IPR2026-00391-ins-TDOC
22 reports for TDOC
Performance horizon
100% Hit rate @ T+1 3 of 3 directional calls Went positive at some point 3 of 3 best @ T+1▲ +2.52%Oct 28, 2026
Filters
Rows
Reports for TDOC, sortable and filterable
TypeNow
Nov 3, 2026
today
3 / PRESS-RELEASE
NEUTRAL ★ 2/10
$8.72awaiting T+1awaiting T+1$9.48 (+8.70%)
Nov 3, 2026
1d ago
PTAB Trial
NEUTRAL ★ 3/10
$9.01awaiting T+1awaiting T+1$9.48 (+5.26%)
Oct 28, 2026
6d ago
Press Release
BEARISH ★ 6/10
No priceawaiting T+1awaiting T+1No price
Oct 28, 2026
6d ago
8-K
BEARISH ★ 6/10
$8.73 $8.51▲ +2.52%▲ +0.75%$9.48 (−8.58%)
Oct 28, 2026
7d ago
PTAB Trial
NEUTRAL ★ 3/10
$8.73 $8.51▼ −2.52%▼ −0.75%$9.48 (+8.58%)
Oct 8, 2026
26d ago
SC 13G
NEUTRAL ★ 3/10
$5.54 $5.77▲ +4.15%▲ +3.55%$9.48 (+71.10%)
Sep 25, 2026
5w ago
8-K
NEUTRAL ★ 3/10
$6.09 $5.89▼ −3.28%▼ −2.54%$9.48 (+55.65%)
Sep 11, 2026
7w ago
144
NEUTRAL ★ 2/10
$6.16 $6.50▲ +5.52%▲ +5.97%$9.48 (+53.88%)
Sep 3, 2026
8w ago
Insider Cluster
NEUTRAL ★ 2/10
$6.28 $6.26▼ −0.32%▲ +0.23%$9.48 (+50.94%)
Sep 2, 2026
8w ago
144
NEUTRAL ★ 2/10
$6.46 $6.47▲ +0.15%▼ −0.89%$9.48 (+46.73%)
Showing 10 of 22

US Market Status

Market Open · Closes in 3h 49m

Subscribe to SecBot

Get Real-Time PTAB Decision Intelligence

Market-moving PTAB patent decisions analyzed within minutes. Trial institutions, denials, final written decisions, and more, parsed and scored by AI.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
⚖ PTAB Decision · ptacts.uspto.gov Report published Nov 3, 2026